Institutional Investment Pitches
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
In its 4Q25 commentary, Conestoga Capital Advisors discusses the performance of its strategies in a year marked by extreme volatility and narrow, speculative leadership. The flagship Small...
— Derek Johnston
Full equity research memos, financial breakdowns, and hedge fund thesis write-ups are reserved for BSD Research ($55/mo) and Pro subscribers.
Already a Research or Pro subscriber? Sign In
Other investors who've written on Stevenato Group SpA
STVN provides drug containment and delivery solutions to pharmaceutical and biotechnology companies.
As businesses with unique and uncorrelated return drivers, Daikin and Corteva complement our existing Reversionary investments, such as pharmaceutical glass manufacturer Stevanato (STVN